The Role of Lymphadenectomy in Treating Liver Cancer
Author Information
Author(s): Gabriele Spoletini, Mauro Alberto, Miriam Caimano, Giuseppe Marrone, Francesco Frongillo, Salvatore Agnes, Quirino Lai, Giuseppe Bianco
Primary Institution: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Hypothesis
Does lymphadenectomy improve survival outcomes in patients with hepatocellular carcinoma undergoing hepatic resection?
Conclusion
Lymph node dissection does not improve overall survival in patients with hepatocellular carcinoma.
Supporting Evidence
- Patients with lymph node metastases had higher mortality rates at 1, 3, and 5 years compared to those without lymph node involvement.
- Only a small percentage of patients undergoing lymphadenectomy showed improved survival outcomes.
- Current evidence does not support routine lymphadenectomy in liver cancer surgery.
Takeaway
The study looked at whether removing lymph nodes during liver cancer surgery helps patients live longer. It found that it doesn't really help.
Methodology
A systematic review and meta-analysis of studies comparing lymphadenectomy with hepatic resection alone.
Potential Biases
Selection bias due to the focus on specific patient populations and retrospective data.
Limitations
The studies included were mostly retrospective and had high heterogeneity in definitions and outcomes.
Participant Demographics
Among 39,823 patients, 67.4% were male, and the majority underwent minor hepatic resection.
Statistical Information
P-Value
p < 0.001
Confidence Interval
95% CI 2.52–4.21
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website